Abstract
A severe bone loss in pharmacoresistant epilepsy associates with enzyme-inducing antiepileptic drug (P1.5-006)
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have